Category Archives: Supply Chain

CDER Addresses 'Challenges of Globalization' With a New Office

In recognition of the difficulties presented by a rapidly expanding global drug market, FDA’s Center for Drug Evaluation and Research (CDER) has created a new office “dedicated to addressing the challenges of globalization and an increasingly complex drug supply chain,” according to memo sent by CDER director Janet Woodcock. The new “Office of Drug Security, […]
Also posted in FDA, Global, Regulatory, Safety | Tagged , , | Leave a comment

Europe Unites Over Counterfeiting

Imitation may the sincerest form of flattery, but it isn’t always welcome. Particularly when the imitations are fakes through and through. That explains why Europe’s new rules to combat counterfeit medicines are winning such widespread applause, says Reflector. It isn’t customary for European Union legislation to win backing from all sides. Usually, there’s a large […]
Also posted in Europe, Global, Guest Blog | Tagged , , | Leave a comment

What Happens When the Pharmaceutical Supply Chain Goes Global?

A report by PwC on managing the global supply chain—based on a survey of industry  executives around the globe—provides a road map for achieving real-time control over the supply chain, as well as a call to action for better collaboration with suppliers, distributors, shippers and regulators. Global pharmaceutical outsourcing has become increasingly prevalent, but is […]
Also posted in Global, Strategy | Leave a comment

Report Reveals Global Supply Chain Fears

A new report published by Axendia is calling for better collaboration with suppliers, distributors, shippers, and regulators. Global pharmaceutical outsourcing has become increasingly prevalent, but is creating a complex and risky supply chain environment that has pharmaceutical and life sciences executives on high alert, according to a new study co-sponsored by PwC and published last […]
Also posted in Biotech, Emerging Markets, Global | Tagged , , , , | Leave a comment

Brazil Profile: Latin America's Giant Repositions for Pharma Growth

Brazil claims a bright future as a drug research and clinical trials site — but IP issues continue to raise concerns among the multinational investor community. Health and regulatory officials of Brazil are making the rounds with a message for pharmaceutical companies and clinical research sponsors about what a great place it is to do […]
Also posted in Emerging Markets, FDA, Global, Legal, Manufacturing, R&D, Regulatory, Strategy | Leave a comment
  • Categories

  • Meta